Authors

• Maggie Nguyen (ORCID: https://orcid.org/0009-0000-1205-0783)
• Ivan Koychev (ORCID: https://orcid.org/0000-0001-6813-8493)
• Svati H. Shah (ORCID: https://orcid.org/0000-0002-3495-2830)
• Graham Reid (ORCID: https://orcid.org/0000-0002-6079-9323)
• Rury R. Holman (ORCID: https://orcid.org/0000-0002-1256-874X)
• Dan W. Joyce (ORCID: https://orcid.org/0000-0002-9433-5340)
• Robert John Mentz (ORCID: https://orcid.org/0000-0002-3222-1719)

Institutions

• Duke University (US)
• University of Oxford (GB)
• Clinical Research Institute (US)
• Duke Institute for Health Innovation (US)
• Oxford Centre for Diabetes, Endocrinology and Metabolism (GB)
• Duke University Health System (US)
• Science Oxford (GB)

Publication Details

Journal

Alzheimer s Research & Therapy

Published

2024-10-02

DOI

https://doi.org/10.1186/s13195-024-01573-x

Citations

22

Primary Topic

Diabetes Treatment and Management

Type

article

Field-Weighted Citation Impact

7.87

Funders

• Amylin Pharmaceuticals
• AstraZeneca
• National Institute for Health and Care Research
• University of Oxford
• Duke Clinical Research Institute